Lessee, Operating Lease, Liability, to be Paid of Sonnet BioTherapeutics Holdings, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary: Sonnet BioTherapeutics Holdings, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
Sonnet BioTherapeutics Holdings, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending 30 Sep 2025 was $48,216, a 66% decline year-over-year.
Source SEC data: View on sec.gov

Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)

Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

Sonnet BioTherapeutics Holdings, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$48,216	-$95,487	-66%	30 Sep 2025	10-K	16 Dec 2025	2025	FY
Q3 2024	$143,703	-$93,614	-39%	30 Sep 2024	10-K	17 Dec 2024	2024	FY
Q3 2023	$237,317	-$79,259	-25%	30 Sep 2023	10-K	14 Dec 2023	2023	FY
Q3 2022	$316,576			30 Sep 2022	10-K	15 Dec 2022	2022	FY
Q2 2022	$341,263			30 Jun 2022	10-Q	15 Aug 2022	2022	Q3
Q4 2019	$27,659,890			31 Dec 2019	10-K	19 Mar 2020	2019	FY
Q3 2019	$29,228,779			30 Sep 2019	10-Q	14 Nov 2019	2019	Q3
Q2 2019	$31,655,501			30 Jun 2019	10-Q	14 Aug 2019	2019	Q2
Q1 2019	$32,764,667			31 Mar 2019	10-Q	15 May 2019	2019	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.